Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival.

Rastellini C, Salam A, Kuddus R, Aitouche A, Subbotin V, Braun M, Leach R, Peach R, Fung JJ, Starzl TE, Rao AS. Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival. Transplant Proc. 1999 Feb-Mar; 31(1-2):1242-3.

View in: PubMed

collapse authors with profiles